EJENDOMSSELSKABET SMEDEGADE ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.3% 2.8% 2.3% 2.3% 1.9%  
Credit score (0-100)  56 59 63 64 69  
Credit rating  BBB BBB BBB BBB A  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.2  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  156 108 129 133 156  
EBITDA  156 108 129 133 156  
EBIT  156 108 129 133 156  
Pre-tax profit (PTP)  50.6 96.6 118.4 123.4 146.2  
Net earnings  -246.9 75.4 92.3 96.3 114.0  
Pre-tax profit without non-rec. items  50.6 96.6 118 123 146  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  3,810 3,810 3,810 3,810 3,810  
Shareholders equity total  1,333 1,408 501 597 711  
Interest-bearing liabilities  1,779 1,669 2,594 2,525 2,466  
Balance sheet total (assets)  3,853 3,929 3,932 3,923 3,898  

Net Debt  1,775 1,550 2,475 2,414 2,388  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  156 108 129 133 156  
Gross profit growth  -11.4% -30.6% 19.4% 3.4% 16.5%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,853 3,929 3,932 3,923 3,898  
Balance sheet change%  0.6% 2.0% 0.1% -0.2% -0.6%  
Added value  155.7 108.0 129.0 133.4 155.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.1% 2.8% 3.3% 3.4% 4.0%  
ROI %  4.2% 2.9% 3.5% 3.6% 4.2%  
ROE %  -17.0% 5.5% 9.7% 17.5% 17.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  34.6% 35.8% 12.7% 15.2% 18.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,140.0% 1,435.3% 1,918.5% 1,809.1% 1,535.6%  
Gearing %  133.5% 118.6% 518.3% 423.0% 346.9%  
Net interest  0 0 0 0 0  
Financing costs %  5.8% 0.7% 0.5% 0.4% 0.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.1 0.3 0.1 0.1 0.1  
Current Ratio  0.1 0.3 0.1 0.1 0.1  
Cash and cash equivalent  3.7 119.0 119.4 110.3 77.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -248.7 -268.2 -1,270.2 -1,268.1 -1,246.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0